Measurement of opsonophagocytic activity of antibodies specific to Neisseria meningitidis serogroup A capsular polysaccharide-serogroup B outer membrane vesicle conjugate in animal model

Annals of Microbiology

Volumn 59, Issue 4, 2009, Pages 801-806

  Kheirandish, Maryam ^a   Siadat, Seyed Davar ^b   Norouzian, Dariush ^b   Razavi, Mohamad Reza ^b   Aghasadeghi, Mohammad Reza ^b   Rezaei, Nima ^c   Farazmand, Ali ^d   Mobarakeh, Jalal Izadi ^b   Zangeneh, Mehrangiz ^e   Moshiri, Arfa ^f   Sadat, Seyed Mehdi ^b   Salmani, Ali Sharifat ^b  

^a IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF TEHRAN   (Iran)

^e ISLAMIC AZAD UNIVERSITY   (Iran)

^f IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Flow cytometric assay; Glycoconjugate; Neisseria meningitidis serogroups A and B; Opsonophagocytosis; Outer membrane vesicle

Indexed keywords

ANIMALIA; BACTERIA (MICROORGANISMS); NEISSERIA MENINGITIDIS; NEISSERIA MENINGITIDIS SEROGROUP A; OAT MOSAIC VIRUS; ORYCTOLAGUS CUNICULUS;

EID: 77951799577     PISSN: 15904261     EISSN: 18692044     Source Type: Journal    
DOI: 10.1007/BF03179226     Document Type: Article

References (26)

1. Aase A., Bjune G., Hoiby E.A., Rosenqvist E., Pedersen A.K., Michaelsen T.E. (1995). Comparison among opsonic activity, antimeningococcal immunoglobulin G response, and serum bactericidal activity against meningococci in sera from vaccinees after immunization with a serogroup B outer membrane vesicle vaccine. Infect. Immun., 63 (9): 3531-3536.
2. Aase A., Hoiby E.A., Michaelsen T.E. (1998). Opsonophagocytic and bactericidal activity mediated by purified IgG subclass antibodies after vaccination with the Norwegian group B meningococcal vaccine. Scand. J. Immunol., 47 (4): 388-396.
3. Ada G., Isaacs D. (2003). Carbohydrate-protein conjugate vaccines. Clin. Microbiol. Infect., 9 (2): 79-85.
4. Balmer P., Borrow R. (2004). Serologic correlates of protection for evaluating the response to meningococcal vaccines. Expert. Rev. Vaccines, 3 (1): 77-87.
5. Behzadiyannejad Q., Siadat S.D., Kheirandish M., Tabaraie B., Ahmadi H., Norouzian D., et al. (2008). Comparison among opsonic activity and serum bactericidal activity against meningococci in rabbit sera from vaccines after immunization with outer membrane vesicle of Neisseria meningitidis serogroup B. Res. J. Microbiol., 3 (3): 105-113.
6. Costantino P., Norelli F., Giannozzi A., D'Ascenzi S., Bartoloni A., Kaur S., et al. (1999). Size fractionation of bacterial capsular polysaccharides for their use in conjugate vaccines. Vaccine, 17 (9-10): 1251-1263. (Pubitemid 29132960)
7. Claassen I., Meylis J., van der Ley P., Peeters C., Brons H., Robert J., et al. (1996). Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine. Vaccine, 14 (10): 1001-1008.
8. Fleck R.A., Athwal H., Bygraves J.A., Hockley D.J., Feavers I.M., Stacey G.N. (2003). Optimization of nb-4 and hl-60 differentiation for use in opsonophagocytosis assays. In Vitro Cell Dev. Biol. Anim., 39 (5-6): 235-342.
9. Jansen W.T., Vakevainen-Anttila M., Kayhty H., Nahm M., Bakker N., Verhoef J., et al. (2001). Comparison of a classical phagocytosis assay and a flow cytometry assay for assessment of the phagocytic capacity of sera from adults vaccinated with a pneumococcal conjugate vaccine. Clin. Diagn. Lab. Immunol., 8 (2): 245-250.
10. Jin Z., Chu C., Robbins J.B., Schneerson R. (2003). Preparation and characterization of group A meningococcal capsular polysaccharide conjugates and evaluation of their immunogenicity in mice. Infect. Immun., 71: 5115-5120.
11. Lehmann A.K., Sornes S., Halstensen A. (2000). Phagocytosis: measurement by flow cytometry. J. Immunol. Methods, 243 (1-2): 229-242.
12. Li W., Chung S.C. (2003). Flow cytometric evaluation of leukocyte function in rat whole blood. In Vitro Cell Dev. Biol. Anim., 39 (10): 413-419.
13. Lun A., Schmitt M., Renz H. (2000). Phagocytosis and oxidative burst: reference values for flow cytometric assays independent of age. Clin. Chem., 46 (11): 1836-1839.
14. Martinez J., Pilishvili T., Barnard S., Caba J., Spear W., Romero- Steiner S., et al. (2002). Opsonophagocytosis of fluorescent polystyrene beads coupled to Neisseria meningitidis serogroup A, C, Y, or W135 polysaccharide correlates with serum bactericidal activity. Clin. Diagn. Lab. Immunol., 9 (2):485-488.
15. Rezaei N., Aghamohammadi A., Siadat S.D., Nejati M., Hojat Ahmadi H., Moin M., Pourpak Z., Kamali S., Norouzian D., Tabaraei B., Read R.C. (2007). Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies. Vaccine, 25: 5308-5314.
16. Romero-Steiner S., Frasch C.E., Carlone G., Fleck R.A., Goldblatt D., Nahm M.H. (2006). Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines. Clin. Vaccine Immunol., 13 (2): 165-169.
17. Rosenstein N.E., Perkins B.A., Stephens D.S., Popovic T., Hughes J.M. (2001). Meningococcal disease. N. Engl. J. Med., 344 (18): 1378-1388.
18. Schneerson R., Barrera O., Sutton A., Robbins J.B. (1980). Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates. J. Exp. Med., 152 (2): 361-376.
19. Siadat S.D., Behzadiyannejad Q., Tabaraie B., Ahmadi H., Nejati M. (2006). Extraction and molecular evaluation of Neisseria meningitidis serogroup B outer membrane vesicle containing PorA. Danshvar. Medicine, 65: 57-64.
20. Siadat S.D., Norouzian D. (2007). Meningococcal vaccines: past, present, and future perspective. J. Infect. Develop. Country, 1 (2): 129-146.
21. Siadat S.D., Behzadiannejad Q., Tabaraie B., Ahmadi H., Norouzian D., Najar-Peerayeh S., Nejati M., Hedayati M.H., Zangeneh M. (2007a). Evaluation of serum bactericidal activity specific for Neisseria meningitidis serogroup A and B: effect of immunization with Neisseria meningitidis serogroup A polysaccharide and serogroup B outer membrane vesicle conjugate as a bivalent meningococcus vaccine candidate. Res. J. Microbiol., 2 (5): 436-444.
22. Siadat S.D., Kheirandish M., Norouzian D., Behzadiyannejad Q., Najar Peerayeh S., Zangeneh M., et al. (2007b). A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after immunization with outer membrane vesicle of Neisseria meningitidis serogroup B. Pakistan J. Biol. Sci., 10 (20): 3578-3584.
23. Siadat S.D., Norouzian D., Tabaraie B., Behzadiyannejad Q., Pirayeeh S.N., Nejati M., et al. (2007c). Comparative studies of conjugated capsular polysaccharide of Neisseria meningitidis serogroup A with outer membrane vesicle of Neisseria meningitidis serogroup B. Res. J. Microbiol., 2 (4): 337-345. (Pubitemid 46955791)
24. Vakevainen M., Jansen W., Saeland E., Jonsdottir I., Snippe H., Verheul A., et al. (2001). Are the opsonophagocytic activities of antibodies in infant sera measured by different pneumococcal phagocytosis assays comparable? Clin. Diagn. Lab. Immunol., 8 (2): 363-369.
25. Valdivia R.H., Falkow S. (1998). Flow cytometry and bacterial pathogenesis. Curr. Opin. Microbiol., 1 (3):359-363.
26. WHO - World Health Organization (1976). Requirements for meningococcal polysaccharide vaccine. Tech. Rep. Ser., 594: 50-75.